TTLL3
gene geneOn this page
Also known as DKFZP434B103HOTTL
Summary
TTLL3 (tubulin tyrosine ligase like 3, HGNC:24483) is a protein-coding gene on chromosome 3p25.3, encoding Tubulin monoglycylase TTLL3 (Q9Y4R7). Monoglycylase which modifies alpha- and beta-tubulin, adding a single glycine on the gamma-carboxyl groups of specific glutamate residues to generate monoglycine side chains within the C-terminal tail of tubulin.
Enables protein-glycine ligase activity. Predicted to be involved in several processes, including axoneme assembly; flagellated sperm motility; and protein polyglycylation. Predicted to be located in cilium. Predicted to be active in axoneme; microtubule cytoskeleton; and sperm flagellum.
Source: NCBI Gene 26140 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001387446
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24483 |
| Approved symbol | TTLL3 |
| Name | tubulin tyrosine ligase like 3 |
| Location | 3p25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434B103, HOTTL |
| Ensembl gene | ENSG00000214021 |
| Ensembl biotype | protein_coding |
| OMIM | 619195 |
| Entrez | 26140 |
Gene structure
Transcript identifiers
Ensembl transcripts: 36 — 21 protein_coding, 7 nonsense_mediated_decay, 7 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000310252, ENST00000383827, ENST00000414814, ENST00000417065, ENST00000418745, ENST00000419081, ENST00000422738, ENST00000426827, ENST00000426895, ENST00000427220, ENST00000430390, ENST00000430718, ENST00000430793, ENST00000431204, ENST00000438141, ENST00000438596, ENST00000439814, ENST00000443148, ENST00000452597, ENST00000452823, ENST00000455274, ENST00000459758, ENST00000466245, ENST00000471058, ENST00000473661, ENST00000474948, ENST00000482269, ENST00000483051, ENST00000492440, ENST00000493241, ENST00000496246, ENST00000496526, ENST00000602338, ENST00000685419, ENST00000703870, ENST00000715597
RefSeq mRNA: 24 — MANE Select: NM_001387446
NM_001025930, NM_001366051, NM_001387446, NM_001387447, NM_001387448, NM_001387449, NM_001387450, NM_001387451, NM_001387452, NM_001387453, NM_001387454, NM_001387455, NM_001387456, NM_001387457, NM_001387458, NM_001387459, NM_001387460, NM_001387461, NM_001387462, NM_001387463, NM_001387464, NM_001387465, NM_001387466, NM_001387467
CCDS: CCDS93199, CCDS93200
Canonical transcript exons
ENST00000685419 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001682776 | 9833104 | 9833245 |
| ENSE00003458887 | 9828960 | 9829395 |
| ENSE00003477249 | 9817645 | 9817759 |
| ENSE00003481543 | 9826997 | 9827240 |
| ENSE00003489823 | 9816074 | 9816202 |
| ENSE00003489976 | 9812943 | 9813111 |
| ENSE00003535627 | 9825800 | 9825948 |
| ENSE00003550401 | 9810621 | 9810709 |
| ENSE00003550706 | 9820546 | 9820741 |
| ENSE00003643225 | 9818822 | 9818920 |
| ENSE00003648275 | 9813248 | 9813345 |
| ENSE00003663709 | 9834681 | 9834907 |
| ENSE00003923925 | 9810262 | 9810394 |
| ENSE00003932494 | 9835094 | 9836365 |
Expression profiles
Bgee: expression breadth ubiquitous, 237 present calls, max score 99.03.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.5895 / max 597.0157, expressed in 1585 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 35243 | 2.4235 | 1057 |
| 35244 | 2.0323 | 747 |
| 35241 | 0.9612 | 514 |
| 35240 | 0.8428 | 322 |
| 35242 | 0.3078 | 158 |
| 35239 | 0.0219 | 4 |
Top tissues by expression
263 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 99.03 | gold quality |
| left ovary | UBERON:0002119 | 98.06 | gold quality |
| right ovary | UBERON:0002118 | 97.78 | gold quality |
| endocervix | UBERON:0000458 | 97.73 | gold quality |
| right testis | UBERON:0004534 | 97.39 | gold quality |
| left testis | UBERON:0004533 | 97.33 | gold quality |
| sural nerve | UBERON:0015488 | 97.24 | gold quality |
| peripheral nervous system | UBERON:0000010 | 97.16 | gold quality |
| nerve | UBERON:0001021 | 97.16 | gold quality |
| tibial nerve | UBERON:0001323 | 97.16 | gold quality |
| left uterine tube | UBERON:0001303 | 96.81 | gold quality |
| granulocyte | CL:0000094 | 96.61 | gold quality |
| mucosa of stomach | UBERON:0001199 | 96.60 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.60 | gold quality |
| body of uterus | UBERON:0009853 | 96.55 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.10 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.02 | gold quality |
| ectocervix | UBERON:0012249 | 96.01 | gold quality |
| gall bladder | UBERON:0002110 | 95.66 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 95.56 | gold quality |
| right coronary artery | UBERON:0001625 | 95.49 | gold quality |
| pituitary gland | UBERON:0000007 | 95.20 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.01 | gold quality |
| skin of leg | UBERON:0001511 | 95.00 | gold quality |
| thyroid gland | UBERON:0002046 | 94.95 | gold quality |
| apex of heart | UBERON:0002098 | 94.95 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 94.91 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 94.91 | gold quality |
| skin of abdomen | UBERON:0001416 | 94.88 | gold quality |
| lower esophagus | UBERON:0013473 | 94.74 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.49 |
| E-GEOD-70580 | no | 248.97 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Characterization of another human tubulin tyrosine ligase-like gene family member (PMID:11054573)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ttll3 | ENSDARG00000053728 |
| mus_musculus | Ttll3 | ENSMUSG00000030276 |
| rattus_norvegicus | Ttll3 | ENSRNOG00000009032 |
Paralogs (12): TTLL1 (ENSG00000100271), TTLL12 (ENSG00000100304), TTLL2 (ENSG00000120440), TTLL9 (ENSG00000131044), TTLL4 (ENSG00000135912), TTLL7 (ENSG00000137941), TTLL8 (ENSG00000138892), TTLL10 (ENSG00000162571), TTLL6 (ENSG00000170703), TTLL11 (ENSG00000175764), KPRP (ENSG00000203786), TTLL13 (ENSG00000213471)
Protein
Protein identifiers
Tubulin monoglycylase TTLL3 — Q9Y4R7 (reviewed: Q9Y4R7)
Alternative names: HOTTL, Tubulin–tyrosine ligase-like protein 3
All UniProt accessions (26): A0A8I5KXU2, A0A994J3Y4, A0AAQ5BIG3, C9IZU0, C9JKU2, C9JNK2, C9JNK7, C9JQ30, C9JRM2, C9JSD3, C9JUK0, C9JW59, C9JWZ9, C9JZ73, E5RGZ6, F8WBP6, F8WD18, H0Y5E3, H3BLT7, H7C0T5, H7C197, J3KQB2, Q9Y4R7, R4GMR7, R4GMW2, R4GN12
UniProt curated annotations — full annotation on UniProt →
Function. Monoglycylase which modifies alpha- and beta-tubulin, adding a single glycine on the gamma-carboxyl groups of specific glutamate residues to generate monoglycine side chains within the C-terminal tail of tubulin. Not involved in elongation step of the polyglycylation reaction. Preferentially glycylates a beta-tail peptide over the alpha-tail, although shifts its preference toward alpha-tail as beta-tail glutamylation increases. Competes with polyglutamylases for modification site on beta-tubulin substrate, thereby creating an anticorrelation between glycylation and glutamylation reactions. Together with TTLL8, mediates microtubule glycylation of primary and motile cilia, which is essential for their stability and maintenance. Involved in microtubule glycylation of primary cilia in colon which controls cell proliferation of epithelial cells and plays an essential role in colon cancer development. Together with TTLL8, glycylates sperm flagella which regulates axonemal dynein motor activity, thereby controlling flagellar beat, directional sperm swimming and male fertility.
Subcellular location. Cytoplasm. Cytoskeleton. Cell projection. Cilium. Cilium axoneme. Flagellum axoneme.
Tissue specificity. Expressed in brain, heart, kidney, testis, liver, lung, muscle, spleen, trachea and colon.
Domain organisation. Two conserved structural elements specific among monoglycylases, IS1 and IS2, are involved in glycyl chains initiation. Two conserved structural interfaces likely constitute the binding platforms for tubulin tail and microtubule. Arg-289 is the main determinant for regioselectivity, which segregates between initiases and elongases in all tubulin–tyrosine ligase family. A glutamine residue at this position is found in elongases TTLL6, TTLL9, TTLL11, TTLL13, TTLL10 and favors glutamate-chain elongation, whereas an arginine residue is found in initiases TTLL2, TTLL4, TTLL5, TTLL3, TTLL8 and favors initiation.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y4R7-1 | 1 | yes |
| Q9Y4R7-2 | 2 | |
| Q9Y4R7-5 | 3 | |
| Q9Y4R7-6 | 4 |
RefSeq proteins (24): NP_001021100, NP_001352980, NP_001374375, NP_001374376, NP_001374377, NP_001374378, NP_001374379, NP_001374380, NP_001374381, NP_001374382, NP_001374383, NP_001374384, NP_001374385, NP_001374386, NP_001374387, NP_001374388, NP_001374389, NP_001374390, NP_001374391, NP_001374392, NP_001374393, NP_001374394, NP_001374395, NP_001374396 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004344 | TTL/TTLL_fam | Family |
| IPR051437 | TTLL_monoglycylase | Family |
Pfam: PF03133
Catalyzed reactions (Rhea), 1 shown:
- L-glutamyl-[protein] + glycine + ATP = glycyl-L-glutamyl-[protein] + ADP + phosphate + H(+) (RHEA:67180)
UniProt features (31 total): binding site 12, splice variant 6, sequence variant 6, sequence conflict 2, chain 1, domain 1, site 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y4R7-F1 | 66.67 | 0.40 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 289 (essential for specifying initiation versus elongation step of the glycylase activity)
Ligand- & substrate-binding residues (12): 381; 456; 469; 469; 469; 471; 283; 289–290; 289; 321–324; 334–336; 378–379
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin |
MSigDB gene sets: 125 (showing top):
GOBP_MALE_GAMETE_GENERATION, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, BLALOCK_ALZHEIMERS_DISEASE_UP, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION, GOBP_MICROTUBULE_BUNDLE_FORMATION, GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS, GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY, BASAKI_YBX1_TARGETS_DN, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_AXONEME_ASSEMBLY
GO Biological Process (5): spermatogenesis (GO:0007283), flagellated sperm motility (GO:0030317), axoneme assembly (GO:0035082), cilium assembly (GO:0060271), protein modification process (GO:0036211)
GO Molecular Function (6): ATP binding (GO:0005524), metal ion binding (GO:0046872), protein-glycine ligase activity (GO:0070735), protein-glycine ligase activity, initiating (GO:0070736), nucleotide binding (GO:0000166), ligase activity (GO:0016874)
GO Cellular Component (10): cytosol (GO:0005829), microtubule (GO:0005874), cilium (GO:0005929), axoneme (GO:0005930), microtubule cytoskeleton (GO:0015630), sperm flagellum (GO:0036126), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), motile cilium (GO:0031514), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cytoskeleton | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| microtubule bundle formation | 1 |
| cellular component assembly | 1 |
| cilium assembly | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| protein metabolic process | 1 |
| macromolecule modification | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| cation binding | 1 |
| acid-amino acid ligase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| protein-glycine ligase activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| catalytic activity | 1 |
| cytoplasm | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| 9+2 motile cilium | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
514 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TTLL3 | TTLL7 | Q6ZT98 | 596 |
| TTLL3 | RHBDL1 | O75783 | 423 |
| TTLL3 | IFT70B | Q8N4P2 | 416 |
| TTLL3 | TTLL4 | Q14679 | 401 |
| TTLL3 | UNC50 | Q53HI1 | 399 |
| TTLL3 | C12orf54 | Q6X4T0 | 392 |
| TTLL3 | TTLL6 | Q8N841 | 381 |
| TTLL3 | ATAT1 | Q5SQI0 | 373 |
| TTLL3 | MON1B | Q7L1V2 | 366 |
| TTLL3 | SVBP | Q8N300 | 366 |
| TTLL3 | AGTPBP1 | Q9UPW5 | 364 |
| TTLL3 | FANCD2OS | Q96PS1 | 354 |
| TTLL3 | AGBL5 | Q8NDL9 | 331 |
| TTLL3 | TTLL13 | A6NNM8 | 328 |
| TTLL3 | TTLL10 | Q6ZVT0 | 326 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TTLL3 | ARPC4-TTLL3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CDCA5 | TTLL3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TTLL3 | TCP1 | psi-mi:“MI:0914”(association) | 0.350 |
| rpoB | TTLL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (29): TTLL3 (Affinity Capture-MS), CCT7 (Affinity Capture-MS), HSPA1L (Affinity Capture-MS), CCT3 (Affinity Capture-MS), CCT6B (Affinity Capture-MS), CCT6A (Affinity Capture-MS), TCP1 (Affinity Capture-MS), CCT4 (Affinity Capture-MS), CCT2 (Affinity Capture-MS), PDCL (Affinity Capture-MS), ZNHIT2 (Affinity Capture-MS), SUFU (Affinity Capture-MS), CCT2 (Affinity Capture-MS), CCT3 (Affinity Capture-MS), SUFU (Affinity Capture-MS)
ESM2 similar proteins: A2APC3, A3KMI0, A4Q9E4, A4Q9E5, A4Q9F0, A4Q9F1, A6H8T7, A8X9V4, B2GUB3, E9P886, F7E540, H2KZM9, O48709, O75164, Q09647, Q0P4M4, Q1ECV4, Q3SXZ7, Q3SZH6, Q4R632, Q4V8A3, Q58DC8, Q5R978, Q5RD88, Q5U5Z8, Q62240, Q641W7, Q6DTM3, Q6EEF3, Q6EMB2, Q6P158, Q6P5D3, Q6ZT98, Q80TF6, Q80Z32, Q8BW72, Q8CDK2, Q8CDP0, Q8CHB8, Q8K3E5
Diamond homologs: A2APC3, A4Q9E4, A4Q9E5, A4Q9E8, A4Q9F6, A6NNM8, A6PVC2, A8CVX7, B2GUB3, O95922, P0CAZ0, Q0VC71, Q1ECV4, Q23K29, Q23SI8, Q3SXZ7, Q3SZH6, Q4R7H0, Q564U4, Q5PPI9, Q5R978, Q641W7, Q6EEF3, Q6EMB2, Q8CHB8, Q8N841, Q91V51, Q9BWV7, Q9Y4R7, A4Q9F0, A4Q9F1, A4Q9F4, A8X9V4, E9P886, F7E540, H2KZM9, P38160, P38584, Q09647, Q14679
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3905 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:9810189:G:GT | donor_gain | 1.0000 |
| 3:9810705:TCAAG:T | donor_loss | 1.0000 |
| 3:9810706:CAAGG:C | donor_loss | 1.0000 |
| 3:9810707:AAGG:A | donor_loss | 1.0000 |
| 3:9810708:AGGTC:A | donor_loss | 1.0000 |
| 3:9810709:GGTCA:G | donor_loss | 1.0000 |
| 3:9810710:G:GA | donor_loss | 1.0000 |
| 3:9810711:T:G | donor_loss | 1.0000 |
| 3:9812935:C:G | acceptor_gain | 1.0000 |
| 3:9812936:A:AG | acceptor_gain | 1.0000 |
| 3:9812937:T:G | acceptor_gain | 1.0000 |
| 3:9812938:T:TA | acceptor_gain | 1.0000 |
| 3:9812939:GCA:G | acceptor_loss | 1.0000 |
| 3:9812940:CA:C | acceptor_loss | 1.0000 |
| 3:9812941:A:AG | acceptor_gain | 1.0000 |
| 3:9812941:AG:A | acceptor_loss | 1.0000 |
| 3:9812942:G:GA | acceptor_gain | 1.0000 |
| 3:9812942:GC:G | acceptor_gain | 1.0000 |
| 3:9812942:GCA:G | acceptor_gain | 1.0000 |
| 3:9812942:GCAGA:G | acceptor_gain | 1.0000 |
| 3:9813107:GGATG:G | donor_gain | 1.0000 |
| 3:9813108:GATG:G | donor_gain | 1.0000 |
| 3:9813108:GATGG:G | donor_gain | 1.0000 |
| 3:9813109:ATG:A | donor_gain | 1.0000 |
| 3:9813109:ATGG:A | donor_loss | 1.0000 |
| 3:9813110:TG:T | donor_gain | 1.0000 |
| 3:9813110:TGGT:T | donor_loss | 1.0000 |
| 3:9813111:GG:G | donor_gain | 1.0000 |
| 3:9813111:GGTG:G | donor_loss | 1.0000 |
| 3:9813112:G:GC | donor_loss | 1.0000 |
AlphaMissense
5347 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000014508 (3:9816365 T>C), RS1000075445 (3:9818378 T>G), RS1000147122 (3:9819896 T>C), RS1000236905 (3:9817821 G>A,C), RS1000271691 (3:9824457 C>T), RS1000536305 (3:9818113 A>G), RS1000590819 (3:9807949 A>G), RS1000609048 (3:9823250 G>A), RS1000852254 (3:9829905 T>C), RS1000911661 (3:9835964 C>A), RS1001024474 (3:9835683 C>A,T), RS1001117819 (3:9833552 CA>C,CAA), RS1001170246 (3:9833336 C>A), RS1001273677 (3:9812595 C>G), RS1001373238 (3:9829634 A>C,G)
Disease associations
OMIM: gene MIM:619195 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| K 7174 | increases expression | 1 |
| bisphenol Z | increases expression | 1 |
| bisphenol S | decreases expression, affects cotreatment | 1 |
| NSC 689534 | affects binding, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Acetylglucosamine | decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Copper | affects binding, increases expression | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Niclosamide | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Smoke | increases expression | 1 |
| Theophylline | affects binding | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.